| Subject: | CDC Issues Interim Recommendations for PPSV23 Vaccination During Novel H1N1 Pandemic |
| Category: | Centers for Disease Control and Prevention (CDC)
|
| Published: | Tue, 16 Jun 2009 - 12:00 pm |
| The Centers for Disease Control and Prevention (CDC) has issued interim guidance describing which groups should be vaccinated with the 23-valent pneumococcal polysaccharide vaccine (PPSV23) to prevent pneumococcal infections during the novel influenza A (H1N1) pandemic. According to the CDC the following recommendations should be followed regarding PPSV23 vaccination:Universal vaccination all adults 65 years of age and olderPersons aged 2 through 64 years who have one or more of the following... The full article is available to StayAlert subscribers. Click here for a free trial subscription. |
|
RESOURCES:
Customizable Documents and Tools:
External Links:
Related MCN Products:
|
|
StayAlert!® Virtual Compliance Administrator™ keeps clients informed by email of any changes to Federal regulations, including Joint Commission (TJC, formerly JCAHO), CDC, CMS, DHHS, FDA, OSHA, OIG, and many more, and also provides downloadable tools to ensure compliance. StayAlert! is a premium product sold as an annual site-license subscription. With the site license, the client can sign up an unlimited number of users for the email alerts and access to the StayAlert! online regulatory library. The StayAlert! system was designed by healthcare professionals actively working in the healthcare environment, who were faced with attempting to competently provide quality care and services while "doing more with less". StayAlert! provides the answer to efficiently performing a variety of required job components from one centralized virtual location. StayAlert! improves data sharing and communications, thus reducing cost, broadening access and providing a system of documentation and follow-up. |
|
